Jim Cramer Recommends Goldman Sachs Over CME Group

Jim Cramer reviewed CME Group Inc. (NASDAQ:CME) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. When a caller asked about the stock during Mad Money, Cramer said:

No, I worked at Goldman. Why not get a piece of action by working at Goldman or buying the stock in Goldman Sachs, which does incredibly well in this turmoil? This is exactly the kind of market that we did well at Goldman. And I say we, I know I’m an alumnist… When I say Goldman, I did play for Goldman.

CME Group Inc. (NASDAQ:CME) operates global marketplaces for trading futures and options across a number of asset classes, including interest rates, equities, currencies, and commodities. Pelican Bay Capital Management stated the following regarding CME Group Inc. (NASDAQ:CME) in its fourth quarter 2025 investor letter:

In addition to the trading activity we discussed above, we also made the decision to exit our positions in CME Group Inc. (NASDAQ:CME) and ON Semiconductor (ON). Additionally, while CME is a great company and has been an excellent investment for our portfolio, it was at the high end of fair value, and we needed to make room for a new position as the portfolio was at out 20 stock holdings limit.

While we acknowledge the risk and potential of CME as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CME and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.